Skip to main content
  • Login
  • Contact
  • Subscriptions

Search form

Home

Deer Park Tribune

Deer Park weather

  • Home
  • News
  • Sports
  • Obituaries
  • Entertainment
    • Special Sections
    • Talking About...
  • Photos
  • Videos
  • Classifieds
    • Classified Display Ads
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Eli Lilly (NY: LLY )

243.41 USD -0.74 (-0.30%)
Streaming Delayed Price Updated: 11:16 AM EDT, Jul 26, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,090,347
Open 242.57
Bid (Size) 243.38 (1)
Ask (Size) 243.45 (1)
Prev. Close 244.15
Today's Range 242.57 - 245.28
52wk Range 129.21 - 244.55
Shares Outstanding N/A
Dividend Yield 1.40%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Lilly Confirms Date and Conference Call for Second-Quarter 2021 Financial Results Announcement
July 22, 2021
Eli Lilly and Company (NYSE: LLY) will announce its second-quarter 2021 financial results on Tuesday, August 3, 2021. Lilly will also conduct a conference call on that day with the investment community... 
From PR Newswire
Lilly and Incyte provide update on supplemental New Drug Application for baricitinib for the treatment of moderate to severe atopic dermatitis
July 16, 2021
Eli Lilly and Company (NYSE: LLY) and Incyte (NASDAQ:INCY) announced today that the U.S. Food and Drug Administration (FDA) will not meet the Prescription Drug User Fee Act (PDUFA) action date for the... 
From PR Newswire

Performance

YTD
+47.08%
+47.08%
1 Month
+5.73%
+5.73%
3 Month
+30.02%
+30.02%
6 Month
+14.63%
+14.63%
1 Year
+51.66%
+51.66%

More News

Read More
Lilly and Banner Alzheimer's Institute collaborate on planned Phase 3 prevention trial of donanemab
July 15, 2021
From PR Newswire
Lilly Announces Acquisition of Protomer Technologies
July 14, 2021
From PR Newswire
Interesting LLY Put And Call Options For September 3rd
July 22, 2021
Tags Stocks
From Market News Video
3 Biotech Stocks That Could Rocket Higher
July 24, 2021
Tags Market News RIGL LLY
From Motley Fool
3 Biotechs That Could Make Big Acquisitions This Year
July 22, 2021
Tags Market News GILD VRTX
From Motley Fool
3 Surprising Stocks That Have Crushed the Market so Far This Year
July 22, 2021
Tags Market News HCA LLY
From Motley Fool
AbbVie, Lilly Atopic Dermatitis Treatments Hit With Further Delays With FDA
July 16, 2021
Tags Benzinga General ABBV
From Benzinga
2 Compelling Reasons to Buy This Reawakened Pharma Giant
July 19, 2021
Tags Market News NVS AZN
From Motley Fool
The Week Ahead In Biotech: Earnings Kickstart With J&J And Biogen, Albireo Awaits FDA Decisions, More IPOs
July 18, 2021
Tags Pharma/Biotech Market News Stocks / Equities
From Blogs - TalkMarkets
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Copyright © 2020 The Deer Park Tribune | 104 N. Main Street | Deer Park, WA 99006 | (509) 276-5043
All property rights for the entire contents of this publication shall be the property of The Deer Park Tribune.
No part hereof may be reproduced without prior written consent.
Privacy and Terms of Use


Site Design, Programming & Development by Surf New Media